Trials / Unknown
UnknownNCT04878679
Effect of WB-EMS on Parkinson's Disease
Effects of Combined Whole Body Electromiostimulation (WB-EMS) and Dynamic Movements on Motor and Cognitive Performance, Neurotrophic Factors and Alpha-synuclein in Parkinson's Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Università degli studi di Roma Foro Italico · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The aim is to establish adequate and suitable protocols for PD patients and to determine the WB-EMS effects on muscle strength, balance, walking, cognitive functions,neurotrophic factors and alpha-synuclein. Thirty-six PD patients, aged from 50 to 80 years, will be recruited and randomly assigned to two experimental groups (EGs and EGc) and one control group (CG), in order to perform dynamic movements with WB-EMS. EGs will undergo to 12-20 minutes of progressive supervised WB-EMS (4 sec. 85 HZ and 4 sec. rests) combined to light dynamic movements, two-time per week for 12/24 weeks. EGe will undergo to 12-20 minutes of progressive supervised WB-EMS 7 Hz) combined with cardiovascular training with rowing machine. CG will not perform any type of physical activity. Pre and post intervention assessment will be carried out on the following areas: physical assessment, neurocognitive, neurotrophic factors and alpha-synuclein assesments. A 3 months follow-up will be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Strenght training combined with WB-EMS | Bodyweight exercise training combined with WB-EMS (2 times/week) with a 85Hz electrical impulse |
| OTHER | Cardiovascular training with WB-EMS | Cardiovascular training , using the rowing machine, combined with WB-EMS (2 times/week) with a 7Hz electrical impulse |
| OTHER | Control group | No physical activity |
Timeline
- Start date
- 2021-04-15
- Primary completion
- 2022-09-23
- Completion
- 2023-04-30
- First posted
- 2021-05-07
- Last updated
- 2023-05-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04878679. Inclusion in this directory is not an endorsement.